ArticleMolecular cancer therapeutics2012

MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cells.

Jenny M Kreahling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.